Pharmacological treatment of depression in persons with epilepsy has b
een an area of controversy because some drugs commonly are perceived s
pecifically to induce or exacerbate seizures in patients with seizure
disorders. This prevailing misconception is unjustified by scientific
studies, yet it continues to prevent afflicted persons from receiving
appropriate therapy. The scientific literature shows that tricyclic an
tidepressant drugs cause seizures in overdose in both animals and huma
ns. In lower doses, these drugs have anticonvulsant activity in humans
and animals. Thus, the antidepressant drugs are like several antiepil
eptic drugs that can both prevent. and cause seizures. The anticonvuls
ant activity of antidepressant drugs has been studied extensively in a
nimals and almost certainly stems from their capacity to block norepin
ephrine and/or serotonin reuptake. The pharmacodynamic action responsi
ble for their convulsant effects has not been well studied but may be
due to their local anesthetic, antihistaminic, or antimuscarinic activ
ity. The newer, more selective monoamine uptake blockers have very low
convulsant liability, and it is suggested that their anticonvulsant a
ctivity, which is well documented in animals, be investigated further
in humans. If their effects in humans are analogous to those in animal
s, these drugs can be used safely in epileptic patients with depressio
n, and it is possible that their anticonvulsant activity can be exploi
ted for use in the treatment of epilepsy. Copyright (C) 1996 Elsevier
Science Inc.